From fetus to 8: the CHILD Cohort Study - Summary - MDSpire

From fetus to 8: the CHILD Cohort Study

  • By

  • Kozeta Miliku

  • Myrtha E Reyna

  • Maria Medeleanu

  • Ruixue Dai

  • Aimee Dubeau

  • Diana L Lefebvre

  • Kim Wright

  • Bassel Dawod

  • Marshall Beck

  • Elissa Brooks

  • Michael Kobor

  • Qingling Duan

  • Jeffrey R Brook

  • Wendy Lou

  • Fiona S L Brinkman

  • Geoffrey L Winsor

  • Justin Cook

  • Allan B Becker

  • Elinor Simons

  • Piushkumar J Mandhane

  • Theo J Moraes

  • Meghan B Azad

  • Malcolm R Sears

  • Stuart E Turvey

  • Padmaja Subbarao

  • The CHILD Study Investigators

  • October 11, 2024

  • 0 min

Share

Objective:

To examine the role of complex genetic-environment interactions from fetal life until young adulthood in the development of health and disease, particularly focusing on asthma, allergies, and other noncommunicable diseases, while also acknowledging the study's expansion to include additional health outcomes.

Key Findings:
  • Study retention was 96.0% at 1 year, 93.2% at 5 years, and 90.7% at 8 years.
  • The study has expanded to include various health outcomes beyond asthma and allergies, such as growth, obesity, and mental health, as well as a subcohort focusing on the impact of COVID-19.
  • Data collection during the COVID-19 pandemic was adapted to virtual visits.
Interpretation:

The CHILD Cohort Study provides a comprehensive platform for understanding early life factors associated with chronic diseases, emphasizing the importance of genetic and environmental interactions while also addressing a broader range of health outcomes.

Limitations:
  • Data collection was partially affected by the COVID-19 pandemic, which may limit the completeness of certain datasets.
  • The study's findings may not be generalizable beyond the Canadian population.
Conclusion:

The CHILD Cohort Study is a valuable resource for researchers, offering extensive data on early life development and health outcomes, with ongoing assessments planned into adolescence and adulthood.

Original Source(s)

From fetus to 8: the CHILD Cohort Study

  • by Kozeta Miliku, Myrtha E Reyna, Maria Medeleanu, Ruixue Dai, Aimee Dubeau, Diana L Lefebvre, Kim Wright, Bassel Dawod, Marshall Beck, Elissa Brooks, Michael Kobor, Qingling Duan, Jeffrey R Brook, Wendy Lou, Fiona S L Brinkman, Geoffrey L Winsor, Justin Cook, Allan B Becker, Elinor Simons, Piushkumar J Mandhane, Theo J Moraes, Meghan B Azad, Malcolm R Sears, Stuart E Turvey, Padmaja Subbarao, The CHILD Study Investigators

  • October 11, 2024

Related Content

Advancements in diagnosis, preventive care, and future directions in the holistic management of pediatric asthma

Changes in the Use of Montelukast for Asthma After a US Food and Drug Administration Boxed Warning

From anaphylaxis to eosinophilic esophagitis during omalizumab treatment in a boy with severe asthma and food allergy: a case report